Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
349.92B | 301.50B | 241.90B | 204.71B | 236.35B | Gross Profit |
48.23B | 35.45B | 32.03B | 29.68B | 32.69B | EBIT |
17.98B | 7.68B | 8.41B | 7.51B | 7.29B | EBITDA |
36.35B | 26.44B | 25.38B | 23.73B | 9.50B | Net Income Common Stockholders |
7.92B | 2.44B | 5.43B | 7.38B | -6.90B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
26.70B | 26.11B | 27.55B | 24.14B | 20.66B | Total Assets |
290.34B | 269.28B | 259.96B | 226.07B | 207.33B | Total Debt |
99.37B | 99.16B | 96.58B | 77.49B | 79.11B | Net Debt |
72.67B | 73.05B | 69.03B | 53.35B | 58.44B | Total Liabilities |
164.95B | 154.85B | 147.69B | 130.15B | 124.82B | Stockholders Equity |
115.78B | 102.73B | 100.59B | 85.14B | 71.44B |
Cash Flow | Free Cash Flow | |||
18.65B | 4.25B | -11.99B | 5.41B | 9.34B | Operating Cash Flow |
31.64B | 19.41B | 5.80B | 18.26B | 26.36B | Investing Cash Flow |
-15.99B | -17.93B | -20.13B | -12.20B | -18.67B | Financing Cash Flow |
-17.75B | -4.51B | 14.76B | -6.89B | -10.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $854.84B | 22.83 | 10.57% | 1.68% | 19.26% | 14.04% | |
78 Outperform | $5.09T | 13.14 | 7.87% | 3.19% | 0.24% | 37.62% | |
74 Outperform | $9.38T | 36.64 | 10.53% | 0.73% | 9.25% | 26.69% | |
67 Neutral | ¥166.58B | 24.81 | 1.94% | 2.31% | -23.23% | ||
61 Neutral | $6.69B | 11.69 | 3.01% | 3.94% | 2.60% | -21.51% | |
57 Neutral | €118.65B | 30.58 | -2.10% | 4.97% | 0.75% | -128.63% | |
52 Neutral | ¥289.83B | 39.80 | 5.41% | -3.42% | -35.09% |